Zeng Li Yang
Amministratore Delegato presso AUTOBIO DIAGNOSTICS CO., LTD.
Posizioni attive di Zeng Li Yang
Società | Posizione | Inizio | Fine |
---|---|---|---|
AUTOBIO DIAGNOSTICS CO., LTD. | Direttore/Membro del Consiglio | 13/11/2012 | - |
Amministratore Delegato | 29/10/2018 | - | |
Corporate Officer/Principal | 13/11/2012 | 29/10/2018 | |
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Zeng Li Yang
Statistiche
Distribuzione geografica
Cina | 3 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AUTOBIO DIAGNOSTICS CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Zeng Li Yang
- Esperienza